Biologics/Immunotherapy News

Early efficacy in treatment may predict clinical response to subcutaneous immunotherapy for allergic rhinitis due to house dust mite allergy at 3 years, according to a letter published in Clinical and Translational Allergy.

Following 6 months of dupilumab treatment, 57% of patients with NSAID-exacerbated respiratory disease had higher aspirin tolerance than before treatment, according to study results published in European Respiratory Journal.

SAN ANTONIO — Patients taking biologics for severe asthma experienced COVID-19 than those who were not taking biologics, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

The FDA has accepted for review the supplemental biologics license application for Dupixent for the treatment of chronic spontaneous urticaria, Regeneron Pharmaceuticals and Sanofi announced in a press release.

Healio compiled the most-read news in allergy, asthma and immunology posted in February.

SAN ANTONIO — Patients with higher reaction thresholds in their food allergies may be easier to treat with oral immunotherapy and see better outcomes, Scott H. Sicherer, MD, FAAP, said in this Healio exclusive video.

SAN ANTONIO — Garadacimab significantly reduced attack rates among patients with hereditary angioedema and was well tolerated, according to an abstract presented at the American Academy of Allergy, Asthma & Immunology Annual meeting.

SAN ANTONIO — Plasminogen activator inhibitor-1, or PAI-1, may serve as a biological marker for severe COVID-19, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

SAN ANTONIO — Allergen immunotherapy helped to relieve eosinophilic esophagitis symptoms and led to remission, according to results of a systematic review presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Oral immunotherapy for egg or peanut allergy appeared safe for children on asthma medication despite greater bronchial hyperresponsiveness in this population, according to a study published in Clinical and Translational Allergy.